1. A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland. (3rd June 2021) Authors: Sipponen, Taina; af Björkesten, Clas-Göran; Hallinen, Taru; Ilus, Tuire; Soini, Erkki; Eberl, Anja; Heikura, Mikko; Kellokumpu, Mikko; Koskela, Ritva; Nielsen, Christian; Nuutinen, Heikki; Heikkinen, Markku; Suhonen, Ulla-Maija; Tillonen, Jyrki; Wennerström, E. Christina M.; Borsi, Andras; Koivun... Journal: Scandinavian journal of gastroenterology Issue: Volume 56:Number 6(2021) Page Start: 661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis—A Danish Register-Based Study From 2003–2015. Issue 9 (20th August 2020) Authors: Vadstrup, Kasper; Alulis, Sarah; Borsi, Andras; Gustafsson, Nina; Nielsen, Agnete; Wennerström, E Christina M; Jørgensen, Tine Rikke; Qvist, Niels; Munkholm, Pia Journal: Inflammatory bowel diseases Issue: Volume 26:Issue 9(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis—A Danish Register-Based Study From 2003–2015. Issue 9 (4th November 2019) Authors: Vadstrup, Kasper; Alulis, Sarah; Borsi, Andras; Gustafsson, Nina; Nielsen, Agnete; Wennerström, E Christina M; Jørgensen, Tine Rikke; Qvist, Niels; Munkholm, Pia Journal: Inflammatory bowel diseases Issue: Volume 26:Issue 9(2020) Page Start: 1377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dose escalation and switching of biologics in ulcerative colitis: a systematic literature review in real-world evidence. (2nd November 2019) Authors: Gemayel, Nathalie C.; Rizzello, Eugenio; Atanasov, Petar; Wirth, Daniel; Borsi, Andras Journal: Current medical research and opinion Issue: Volume 35:Number 11(2019) Page Start: 1911 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Extraintestinal Manifestations and Other Comorbidities in Ulcerative Colitis and Crohn Disease: A Danish Nationwide Registry Study 2003–2016. Issue 3 (25th August 2020) Authors: Vadstrup, Kasper; Alulis, Sarah; Borsi, Andras; Jørgensen, Tine Rikke; Nielsen, Agnete; Munkholm, Pia; Qvist, Niels Journal: Crohn's & colitis 360 Issue: Volume 2:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Increased use of biologics in the era of TNF-α inhibitors did not reduce surgical rate but prolonged the time from diagnosis to first time intestinal resection among patients with Crohn's disease and ulcerative colitis – a Danish register-based study from 2003–2016. (4th May 2021) Authors: Qvist, Niels; Vadstrup, Kasper; Alulis, Sarah; Borsi, Andras; Munkholm, Pia; Olsen, Jens Journal: Scandinavian journal of gastroenterology Issue: Volume 56:Number 5(2021) Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort. Issue 12 (December 2020) Authors: af Björkesten, Clas-Göran; Ilus, Tuire; Hallinen, Taru; Soini, Erkki; Eberl, Anja; Hakala, Kalle; Heikura, Mikko; Jussila, Airi; Koskela, Ritva; Koskinen, Inka; Moilanen, Veikko; Nielsen, Christian; Nieminen, Urpo; Nuutinen, Heikki; Heikkinen, Markku; Suhonen, Ulla-Maija; Tillonen, Jyrki; Utriain... Journal: European journal of gastroenterology & hepatology Issue: Volume 32:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Real-world outcomes associated with switching to anti-TNFs versus other biologics in Crohn's Disease patients: A retrospective analysis using German claims data. (November 2022) Authors: Zhuleku, Evi; Antolin-Fontes, Beatriz; Borsi, Andras; Nissinen, Riikka; Bravatà, Ivana; Barthelmes, Jennifer Norma; Le Bars, Manuela; Lee, Jennifer; Passey, Alun; Maywald, Ulf; Deiters, Barthold; Bokemeyer, Bernd; Wilke, Thomas; Ghiani, Marco Journal: Therapeutic advances in gastroenterology Issue: Volume 15(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Societal costs attributable to Crohn's disease and ulcerative colitis within the first 5 years after diagnosis: a Danish nationwide cost-of-illness study 2002–2016. (2nd January 2020) Authors: Vadstrup, Kasper; Alulis, Sarah; Borsi, Andras; Elkjaer Stallknecht, Sandra; Nielsen, Agnete; Rikke Jørgensen, Tine; Wennerström, Christina; Qvist, Niels; Munkholm, Pia Journal: Scandinavian journal of gastroenterology Issue: Volume 55:Number 1(2020) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Treatment patterns for biologics in ulcerative colitis and Crohn's disease: a Danish Nationwide Register Study from 2003 to 2015. (3rd March 2020) Authors: Alulis, Sarah; Vadstrup, Kasper; Borsi, Andras; Nielsen, Agnete; Rikke Jørgensen, Tine; Qvist, Niels; Munkholm, Pia Journal: Scandinavian journal of gastroenterology Issue: Volume 55:Number 3(2020) Page Start: 265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗